NICE rejects Boehringer's new lung cancer drug in draft guidance

 
• By Lucie Ellis-Taitt
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas